These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
360 related articles for article (PubMed ID: 31165767)
21. ST2 as checkpoint target for colorectal cancer immunotherapy. Van der Jeught K; Sun Y; Fang Y; Zhou Z; Jiang H; Yu T; Yang J; Kamocka MM; So KM; Li Y; Eyvani H; Sandusky GE; Frieden M; Braun H; Beyaert R; He X; Zhang X; Zhang C; Paczesny S; Lu X JCI Insight; 2020 May; 5(9):. PubMed ID: 32376804 [TBL] [Abstract][Full Text] [Related]
22. Targeting tumor-infiltrating CCR8 Chen Q; Shen M; Yan M; Han X; Mu S; Li Y; Li L; Wang Y; Li S; Li T; Wang Y; Wang W; Wei Z; Hu C; Jin A J Transl Med; 2024 Jul; 22(1):709. PubMed ID: 39080766 [TBL] [Abstract][Full Text] [Related]
28. IL-33 Released in the Liver Inhibits Tumor Growth via Promotion of CD4 Jin Z; Lei L; Lin D; Liu Y; Song Y; Gong H; Zhu Y; Mei Y; Hu B; Wu Y; Zhang G; Liu H J Immunol; 2018 Dec; 201(12):3770-3779. PubMed ID: 30446569 [TBL] [Abstract][Full Text] [Related]
29. Detrimental role of IL-33/ST2 pathway sustaining a chronic eosinophil-dependent Th2 inflammatory response, tissue damage and parasite burden during Toxocara canis infection in mice. Leal-Silva T; Vieira-Santos F; Oliveira FMS; Padrão LLS; Kraemer L; da Paixão Matias PH; de Almeida Lopes C; Loiola Ruas AC; de Azevedo IC; Nogueira DS; Rachid MA; Caliari MV; Castro Russo R; Fujiwara RT; Bueno LL PLoS Negl Trop Dis; 2021 Jul; 15(7):e0009639. PubMed ID: 34324507 [TBL] [Abstract][Full Text] [Related]
30. IL-33 Promotes the Development of Colorectal Cancer Through Inducing Tumor-Infiltrating ST2L Zhou Y; Ji Y; Wang H; Zhang H; Zhou H Technol Cancer Res Treat; 2018 Jan; 17():1533033818780091. PubMed ID: 29950152 [TBL] [Abstract][Full Text] [Related]
31. Downregulated miR-524-5p Participates in the Tumor Microenvironment of Ameloblastoma by Targeting the Interleukin-33 (IL-33)/Suppression of Tumorigenicity 2 (ST2) Axis. Chen L; Wang G; Qiao X; Wang X; Liu J; Niu X; Zhong M Med Sci Monit; 2020 Jan; 26():e921863. PubMed ID: 31990904 [TBL] [Abstract][Full Text] [Related]
32. Epithelial-derived IL-33 promotes intestinal tumorigenesis in Apc He Z; Chen L; Souto FO; Canasto-Chibuque C; Bongers G; Deshpande M; Harpaz N; Ko HM; Kelley K; Furtado GC; Lira SA Sci Rep; 2017 Jul; 7(1):5520. PubMed ID: 28710436 [TBL] [Abstract][Full Text] [Related]
33. The IL-33/ST2 axis affects tumor growth by regulating mitophagy in macrophages and reprogramming their polarization. Xu H; Li D; Ma J; Zhao Y; Xu L; Tian R; Liu Y; Sun L; Su J Cancer Biol Med; 2021 Feb; 18(1):172-183. PubMed ID: 33628592 [TBL] [Abstract][Full Text] [Related]
34. Dynamics of the IL-33/ST2 network in the progression of human colorectal adenoma to sporadic colorectal cancer. Cui G; Qi H; Gundersen MD; Yang H; Christiansen I; Sørbye SW; Goll R; Florholmen J Cancer Immunol Immunother; 2015 Feb; 64(2):181-90. PubMed ID: 25324197 [TBL] [Abstract][Full Text] [Related]
35. IL-33/ST2 pathway drives regulatory T cell dependent suppression of liver damage upon cytomegalovirus infection. Popovic B; Golemac M; Podlech J; Zeleznjak J; Bilic-Zulle L; Lukic ML; Cicin-Sain L; Reddehase MJ; Sparwasser T; Krmpotic A; Jonjic S PLoS Pathog; 2017 Apr; 13(4):e1006345. PubMed ID: 28448566 [TBL] [Abstract][Full Text] [Related]
36. Integrated Expression Profiles Analysis Reveals Correlations Between the IL-33/ST2 Axis and CD8 Chen H; Chen Y; Liu H; Que Y; Zhang X; Zheng F Front Immunol; 2018; 9():1179. PubMed ID: 29896199 [TBL] [Abstract][Full Text] [Related]
37. GPR15 Facilitates Recruitment of Regulatory T Cells to Promote Colorectal Cancer. Adamczyk A; Pastille E; Kehrmann J; Vu VP; Geffers R; Wasmer MH; Kasper S; Schuler M; Lange CM; Muggli B; Rau TT; Klein D; Hansen W; Krebs P; Buer J; Westendorf AM Cancer Res; 2021 Jun; 81(11):2970-2982. PubMed ID: 33727229 [TBL] [Abstract][Full Text] [Related]
38. Distribution of Regulatory T-Cells and Other Phenotypes of T-Cells in Tumors and Regional Lymph Nodes of Colorectal Cancer Patients. Kazama K; Otake J; Satoyoshi T; Shiozawa M; Sugano N; Sato S; Atsumi Y; Kano K; Murakawa M; Maezawa Y; Hashimoto I; Numata M; Oshima T; Yukawa N; Rino Y; Sasada T; Masuda M In Vivo; 2020; 34(2):849-856. PubMed ID: 32111794 [TBL] [Abstract][Full Text] [Related]
39. The effects of TNF-α/TNFR2 in regulatory T cells on the microenvironment and progression of gastric cancer. Qu Y; Wang X; Bai S; Niu L; Zhao G; Yao Y; Li B; Li H Int J Cancer; 2022 Apr; 150(8):1373-1391. PubMed ID: 34766338 [TBL] [Abstract][Full Text] [Related]
40. IL-33 Signaling Alters Regulatory T Cell Diversity in Support of Tumor Development. Li A; Herbst RH; Canner D; Schenkel JM; Smith OC; Kim JY; Hillman M; Bhutkar A; Cuoco MS; Rappazzo CG; Rogers P; Dang C; Jerby-Arnon L; Rozenblatt-Rosen O; Cong L; Birnbaum M; Regev A; Jacks T Cell Rep; 2019 Dec; 29(10):2998-3008.e8. PubMed ID: 31801068 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]